Steven L. Hoerter Deciphera Pharmaceuticals, Inc. (DCPH) insider trading activity

Steven L. Hoerter is President and CEO of Deciphera Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of DCPH, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2024, when has been sold 72,763 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Steven L. Hoerter Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	72,763 Reduced 100.0%	0 Common Stock
Jun 11 2024	SELL Sale (or disposition) back to the issuer	-	286,075 Reduced 79.72%	72,763 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	286,075 Added 44.36%	358,838 Common Stock
Dec 13 2023	SELL Open market or private sale	$471,305 $15.37 p/Share	30,664 Reduced 29.65%	72,763 Common Stock
Dec 12 2023	BUY Grant, award, or other acquisition	-	62,500 Added 37.67%	103,427 Common Stock
Oct 30 2023	SELL Open market or private sale	$259,307 $12.02 p/Share	21,573 Reduced 34.52%	40,927 Common Stock
Oct 28 2023	BUY Grant, award, or other acquisition	-	62,500 Added 50.0%	62,500 Common Stock
Mar 21 2023	SELL Open market or private sale	$116,775 $15.57 p/Share	7,500 Reduced 100.0%	0 Common Stock
Feb 14 2023	SELL Open market or private sale	$480,720 $16.0 p/Share	30,045 Reduced 80.02%	7,500 Common Stock
Mar 21 2022	SELL Payment of exercise price or tax liability	$28,696 $9.11 p/Share	3,150 Reduced 7.74%	37,545 Common Stock
Mar 18 2021	SELL Payment of exercise price or tax liability	$134,789 $42.79 p/Share	3,150 Reduced 7.18%	40,695 Common Stock
Jan 21 2021	BUY Exercise of conversion of derivative security	$27,381 $25.4 p/Share	1,078 Added 2.4%	43,845 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

ORIC

Oric Pharmaceuticals, Inc. Healthcare

CCCC

C4 Therapeutics, Inc. Healthcare

Director

SLH

Steven L. Hoerter

President and CEO

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DCPH shares.

Notify only if

Value

Insider Trading

Get notified when an Deciphera Pharmaceuticals, Inc. insider buys or sells DCPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Deciphera Pharmaceuticals, Inc.

Track Activities on DCPH

Account